-
- News
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueCertifications
Certifications have historically been seen as a cost of doing business, but how do we turn them into a positive ROI and a value to both customer and vendor?
The Butterfly Effect
The basis of chaos theory is a key concept known as the “butterfly effect.” It’s the idea that a small event in one place creates a cascading set of events elsewhere. So, how is the EMS landscape changing? We’re tracking the concerns and dynamics of this landscape, and there’s a lot to learn.
Coming to Terms With AI
In this issue, we examine the profound effect artificial intelligence and machine learning are having on manufacturing and business processes. We follow technology, innovation, and money as automation becomes the new key indicator of growth in our industry.
- Articles
- Columns
Search Console
- Links
- Events
||| MENU - smt007 Magazine
Nordson to Acquire Advanced Technologies Business of Vention Medical
February 21, 2017 | NordsonEstimated reading time: 3 minutes
Nordson Corporation has entered into a definitive agreement to acquire Vention Medical's Advanced Technologies (Vention AT) business, a designer, developer and manufacturer of minimally invasive interventional delivery devices, catheters and advanced components for the global medical technology market, for $705 million in an all cash transaction. Headquartered in Salem, New Hampshire, Vention AT reported sales of $150 million and EBITDA of $48 million for the trailing 12 months ended January 31, 2017. The transaction will be financed through cash and debt.
"We are extremely pleased to add a high quality, differentiated market leader in minimally invasive delivery devices and components to Nordson’s existing medical platform," said Michael F. Hilton, Nordson President and Chief Executive Officer. "This acquisition aligns with the medical growth strategy we have consistently articulated, brings significant scale to what is already one of Nordson's fastest growing businesses, and enhances strategically important capabilities including design and development, extrusion, complex medical tubing and balloon manufacturing, nitinol forming and other specialty material expertise. We see Vention AT as an ideal complement to our current offering of single-use fluid management components, biomaterial delivery devices, and high end cannula and tubing, and we are excited to bring our combined capabilities to the many leading medical OEM customers we share."
Vention AT employs approximately 775 people and will operate as part of Nordson’s Advanced Technology Systems segment.
Benefits of the Transaction
- Adds scale in attractive and rapidly growing end markets: Offers leadership position in minimally invasive interventional delivery end markets that are growing at a high single digit rate.
- Enhances strategic manufacturing and product capabilities: Adds design, development, prototyping and regulatory expertise; high end tubing, catheter and balloon manufacturing expertise; material expertise.
- Expands product portfolio: Offers more than 20,000 SKUs to more than 1,500 customers with a significant portion of single use consumables that generate a steady stream of recurring revenue. Highly complementary to Nordson’s current offering of single-use fluid management components, biomaterial delivery devices, and high end cannula and tubing.
- Expands applications and end markets served: Brings expertise in coronary/peripheral vascular, minimally invasive, structural heart, electrophysiology, urology, kyphoplasty and several other high growth therapeutic areas.
- Delivers attractive financial benefits: Expected to accelerate Nordson top and bottom line growth and be accretive to EBITDA margins. Nordson expects $0.05 to $0.10 accretion to EPS in fiscal year 2017, including estimated purchase accounting charges.
- Provides customer synergies: Deepens and expands Nordson’s exposure to large OEM’s and emerging innovators. Selected cross-selling opportunities.
- Provides presence in key medical regions: Footprint in Minneapolis, Ireland and Israel, among others.
- Aligns with articulated acquisition strategy: Follows other successful Nordson acquisitions in the medical space including Value Plastics, Micromedics, LinkTech Quick Couplings and Avalon Catheters.
- Further balances Nordson’s Advanced Technology Systems segment around less cyclical end markets.
Transaction Details and Advisors
Vention Medical is a portfolio company of KRG Capital Partners. Vention Medical consists of the Advanced Technologies (Vention AT) business and a separate Device Manufacturing Services (Vention DMS) business, a contract manufacturing operation not core to Nordson's strategic direction. Nordson's acquisition of Vention AT is expected to close during Nordson’s second fiscal quarter, pending customary regulatory clearances.
As is customary in transactions of this nature, certain information regarding Vention AT is subject to restrictions on disclosure until closing. Following the close of the transaction, additional financial information, including audited financial statements, will be provided by Nordson in its filings with the Securities and Exchange Commission.
Morgan Stanley & Co. LLC is serving as financial advisor to Nordson, and Jones Day is serving as a legal advisor.
About Nordson
Nordson Corporation engineers, manufactures and markets differentiated products and systems used to dispense, apply and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces. These products are supported by application expertise and direct global sales and service. Nordson serves a wide variety of consumer non-durable, durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in nearly 40 countries. Visit Nordson on the web at www.nordson.com.
Suggested Items
Global Flexible Substrate Market Size To Worth USD 2520.19 Million by 2033; CAGR Of 14.50%
07/16/2024 | Globe NewswireThe Global Flexible Substrate Market Size is to Grow from USD 650.62 Million in 2023 to USD 2520.19 Million by 2033, at a Compound Annual Growth Rate (CAGR) of 14.50% during the projected period.
Presto Engineering Achieves Medical Device ISO 13485 Quality Management Certification
07/12/2024 | Presto EngineeringThe certification covers Presto’s Denmark hub to ensure that its ASIC design and production services consistently meet medical device customer expectations and relevant regulatory requirements.
Beck Automation AG Opens New Facility in Dällikon with a Focus on Medical Automation
07/09/2024 | Beck Automation AGBeck Automation AG is pleased to announce the opening of its new facility in Dällikon. This move highlights the ongoing growth and the commitment to providing top-notch service and innovative solutions to the customers of Beck Automation.
Exciting Times Ahead For IMI
07/09/2024 | IMIIntegrated Micro-Electronics, Inc. “These are exciting times ahead of us at IMI,” said Louis Sylvester Hughes, the company’s new CEO, rallying all employees and assuring all stakeholders of the company during a recently held townhall meeting at the company’s headquarters in Laguna. Employees from the company’s offshore sites were also listening online.
UHDI Fundamentals: UHDI Applications for Medical Devices
07/03/2024 | Anaya Vardya, American Standard CircuitsUltra high-density interconnect (UHDI) technology typically refers to advanced printed circuit board (PCB) manufacturing techniques that allow for a higher density of electronic components and interconnections within a smaller area. While not directly related to medical applications on its own, UHDI technology can indirectly benefit various medical devices and equipment by enabling smaller, more compact designs with increased functionality and performance.